Skip to content Skip to footer

The Accelerating Scope of Infection Control in Hospitals: Market Analysis and Future Opportunities

In the last 24 hours, there has been an abundance of information with 1,725 press releases, whereas in the last year, the number stood at a whopping 414,487. This wealth of data provides a landscape perspective to the accelerating prevalence of hospital-acquired infections (HAIs), the escalating risk of epidemic or pandemic breakouts, and the consequential expansion of the hospital-acquired infection control market. Located in Wilmington, Delaware, United States, the report titled ‘Hospital-Acquired Infection Control Market by Product & Service, Infection Type, and End User: Global Opportunity Analysis and Industry Forecast, 2022–2030’ sheds light on the market trends.

The hospital-acquired infection control market, estimated at $19.95 billion in 2020, is projected to reach $25.00 billion by 2030. The data translates to a Compound Annual Growth Rate (CAGR) of 4.6% over the period of 2022 to 2030. The growth is driven predominantly by an upsurge in hospital-acquired infections, an increased likelihood of epidemic or pandemic outbreaks, and a surge in chronic disease incidences.

The market growth, however, faces hurdles in the form of potentially fatal effects of chemical disinfectants. Yet, emerging countries hold high growth potential, opening new avenues for the expansion of the hospital-acquired infection control market.

In terms of product and service, the protective barriers segment dominated the market in 2020, accounting for over three quarters of the global hospital-acquired infection control market. This dominance is attributed to the rising adoption of medical nonwovens such as surgical drapes, face masks, and gowns, which was further fuelled by the Covid-19 pandemic, increasing number of surgeries, and escalating public awareness about personal hygiene. The sterilization segment, though, is predicted to witness the highest CAGR of 5.9% from 2022 to 2030. This projection is based on the rising prevalence of hospital-acquired infections, increased outsourcing of sterilization services, re-introduction of ethylene oxide sterilization, and an upswing in the incidence of chronic diseases such as diabetes, cancer, amongst others.

The pandemic necessitated an expansion in the production capacities of HAI control products like gloves, masks, and gowns. With a rig in the number of Covid-19 cases and an increased need for safety of healthcare workers, the demand for protective barrier products and disposable hospital supplies is projected to soar, providing new avenues for HAI control products manufacturers.

From a geographical perspective, North America held the largest market share in 2020, harboring more than one-third of the global hospital-acquired infection control market. This dominant position is likely to persist until 2030, attributed to the rise in adoption of sterilization & disinfection products, contract sterilization services, and the escalating need for control measures against hospital-acquired infections. Asia-Pacific, however, is estimated to display the fastest CAGR of 5.4% over the forecast period, bolstered by a surge in personal hygiene awareness, increased number of surgical procedures, availability of trained medical professionals, and favorable healthcare reimbursement policies.

From an end-user perspective, the hospitals and clinics segment commanded the highest share in 2020, contributing to more than three-quarters of the global hospital-acquired infection control market. Factors such as an increase in the geriatric population prone to various chronic diseases, a surge in surgical procedures performed in hospitals, and the worldwide rise in the number of hospitals and clinics contribute to this segment’s projected continued dominance through the forecast period.

Contributors to the report included prominent entities in the infection prevention space such as 3M Company, Belimed AG, Ecolab Inc., Fortive (Advanced Sterilization Products), Getinge AB, Matachana Group, Miele Group, MMM Group, Sotera Health LLC, and Steris Plc. (Cantel Medical Corporation).


Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]